Sodemann B, Persson P E, Nilsson O S
Department of Orthopedic Surgery, Central Hospital, Kristianstad, Sweden.
Arch Orthop Trauma Surg (1978). 1988;107(6):329-33. doi: 10.1007/BF00381057.
Prophylactic treatment with indomethacin or ibuprofen to prevent periarticular heterotopic ossification (PHO) was investigated in a consecutive series of 200 total hip replacements (THR) performed for primary coxarthrosis in 170 patients. No widespread PHO (grades III and IV) occurred in 166 THR treated with indomethacin or ibuprofen from the 1st to the 21st postoperative day. Only one patient exhibited moderate (grade-II) ossification. In contrast, the incidence of PHO grades III and IV was found to be high (23%) in the 35 THR for which the patients did not receive prophylaxis according to intention. It was concluded that 3 weeks' postoperative treatment with indomethacin or ibuprofen is sufficient to prevent the development of clinically significant heterotopic ossification.
在170例因原发性髋关节病接受全髋关节置换术(THR)的患者中,对连续200例患者进行了吲哚美辛或布洛芬预防性治疗以预防关节周围异位骨化(PHO)的研究。从术后第1天至第21天,166例接受吲哚美辛或布洛芬治疗的THR未发生广泛的PHO(III级和IV级)。只有1例患者出现中度(II级)骨化。相比之下,35例未按意向接受预防治疗的THR中,PHO III级和IV级的发生率较高(23%)。得出的结论是,术后3周使用吲哚美辛或布洛芬治疗足以预防具有临床意义的异位骨化的发生。